179 related articles for article (PubMed ID: 3098192)
21. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
22. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis.
Igarashi A; Takehara K; Soma Y; Kikuchi K; Ishibashi Y
Dermatologica; 1990; 180(3):136-40. PubMed ID: 2340922
[TBL] [Abstract][Full Text] [Related]
24. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
[TBL] [Abstract][Full Text] [Related]
25. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.
Reimer G; Huschka U; Keller J; Kammerer R; Hornstein OP
Br J Dermatol; 1983 Jul; 109(1):27-36. PubMed ID: 6344904
[TBL] [Abstract][Full Text] [Related]
26. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
27. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
28. The association of antinuclear antibodies, antilymphocyte antibodies, and C4 activation among the relatives of children with systemic lupus erythematosus.
Lehman TJ; Curd JG; Zvaifler NJ; Hanson V
Arthritis Rheum; 1982 May; 25(5):556-61. PubMed ID: 6979340
[TBL] [Abstract][Full Text] [Related]
29. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
[TBL] [Abstract][Full Text] [Related]
30. Antinuclear antibodies in Thai patients with connective tissue diseases.
Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
[TBL] [Abstract][Full Text] [Related]
31. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
[TBL] [Abstract][Full Text] [Related]
32. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
[TBL] [Abstract][Full Text] [Related]
33. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies.
Arnett FC; Bias WB; McLean RH; Engel M; Duvic M; Goldstein R; Freni-Titulaer L; McKinley TW; Hochberg MC
J Rheumatol; 1990 Aug; 17(8):1029-35. PubMed ID: 1976808
[TBL] [Abstract][Full Text] [Related]
34. [The antinuclear antibody spectrum in circumscribed forms of scleroderma].
do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O
Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401
[TBL] [Abstract][Full Text] [Related]
35. Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"?
Morse JH; Barst RJ; Whitman HH; Fotino M; Jacobs JC
J Rheumatol; 1989 Dec; 16(12):1536-41. PubMed ID: 2625683
[TBL] [Abstract][Full Text] [Related]
36. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
37. An immunogenetic study of familial scleroderma.
de Juan MD; Belzunegui J; Belmonte I; Barado J; Figueroa M; Cancio J; Vidal S; Cuadrado E
Ann Rheum Dis; 1994 Sep; 53(9):614-7. PubMed ID: 7979601
[TBL] [Abstract][Full Text] [Related]
38. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
39. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
Zabek J; Palacz A; Pyka J; Krzewska I
Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
[TBL] [Abstract][Full Text] [Related]
40. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
